Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (111-120 of 407) with videos related to

Pageof 41
Sort By:
Translational Lung Cancer Research|January 10, 2022
Assessing the association of diabetes with lung cancer riskAmanda Leiter, Antonios Charokopos, Stacyann Bailey, et al.
Carcinogenesis|February 21, 2004
Low CYP1A2 activity associated with testicular cancerKirsten Vistisen, Steffen Loft, Jørgen H Olsen, et al.
Clinical Lung Cancer|October 14, 2021
The Combiome Hypothesis: Selecting Optimal Treatment for Cancer PatientsFred R Hirsch, Jill Walker, Brandon W Higgs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assayFred R Hirsch, Rafal Dziadziuszko, Marileila Varella-Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?Keith M Kerr, Ming-Sound Tsao, Andrew G Nicholson, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income CountriesFred R Hirsch, Bojan Zaric, Ahmed Rabea, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in small-cell lung cancer: present-day status and promisesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancerShengxiang Ren, Fred R Hirsch, Marileila Varella-Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2017
Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer TransformationKenichi Suda, Isao Murakami, Hui Yu, et al.
Biomedicines|June 28, 2023
Radiotherapy and Immunotherapy in Lung CancerKristin Hsieh, Daniel R Dickstein, Juliana Runnels, et al.
Pageof 41

Showing results (111-120 of 407) with videos related to

Sort By:
Pageof 41
Translational Lung Cancer Research|January 10, 2022
Assessing the association of diabetes with lung cancer riskAmanda Leiter, Antonios Charokopos, Stacyann Bailey, et al.
Carcinogenesis|February 21, 2004
Low CYP1A2 activity associated with testicular cancerKirsten Vistisen, Steffen Loft, Jørgen H Olsen, et al.
Clinical Lung Cancer|October 14, 2021
The Combiome Hypothesis: Selecting Optimal Treatment for Cancer PatientsFred R Hirsch, Jill Walker, Brandon W Higgs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assayFred R Hirsch, Rafal Dziadziuszko, Marileila Varella-Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?Keith M Kerr, Ming-Sound Tsao, Andrew G Nicholson, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income CountriesFred R Hirsch, Bojan Zaric, Ahmed Rabea, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in small-cell lung cancer: present-day status and promisesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancerShengxiang Ren, Fred R Hirsch, Marileila Varella-Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2017
Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer TransformationKenichi Suda, Isao Murakami, Hui Yu, et al.
Biomedicines|June 28, 2023
Radiotherapy and Immunotherapy in Lung CancerKristin Hsieh, Daniel R Dickstein, Juliana Runnels, et al.
Pageof 41